FibroGen (FGEN) Misses Q1 EPS by 6c

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.81), $0.06 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $36.16 million versus the consensus estimate of $31.67 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• BIG3 Basketball to go public via Graf Global merger at $290 million
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance